The immunohistochemistry (IHC) market is on a promising growth trajectory, with an anticipated value of USD 3.5 billion in ...

The company is targeting its RPPA-based testing to biopharma firms as well as for clinical trial work and to clinicians to help guide therapy in cancer patients.

Allied Market Research published a report, titled, "Breast Cancer Screening Market by Test Type (Blood Marker Test, Genetic Test, Imaging Test and Immunohistochemistry Test), by Gender (Male and ...

Melanoma-associated antigen A6 (MAGEA6) is well known to have oncogenic activity, but the underlying mechanisms by which it regulates tumor progression and chemo-resistance, especially in ...

Immunoblotting and immunohistochemistry confirmed the loss of CDK12 protein. To describe more explicitly how the loss of ...

Siriraj Hospital excels in maintaining its high standards for every service, including diagnostics through the integration of cutting-edge technology into its medical services, furthering its mission ...

How have immunohistochemistry and immunofluorescence been adapted to fit the growing needs of the life science research ...

The FDA expects to issue a decision in the first quarter of 2025, and if the agency grants approval, it will expand the biomarker-eligible population for the drug.

Provides updates on BioNTech’s strategy to scale and deploy AI-capabilities across the immunotherapy pipelineHighlights InstaDeep’s new near exascale supercomputer, Kyber, with the aim of enabling ...

The firm last week announced it received funding that will allow it to complete development of the test, called Myelo-Scan, by the end of 2026.

The companies will initially develop an AI-based test to select patients with CDH17-expressing gastrointestinal cancers for Arbele's Phase I drug trial.

The global anatomic pathology market was valued at approximately USD 35.17 billion in 2023 and is expected to expand at a compound annual growth rate (CAGR) of 8.2% from 2024 to 2032, surpassing USD ...